Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage

A Carter, P Sarda, M George, S Corbett

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)

    Abstract

    We report a fatality due to massive gastrointestinal haemorrhage in a patient receiving prophylactic dabigatran etexilate following a total hip replacement. A 79-year-old woman was commenced on dabigatran for venous thromboembolic prophylaxis following a total hip replacement. She presented again four days after surgery with haematemesis and hypotension but her coagulopathy could not be corrected, leading to her death. This case highlights the lack of reversal agent for dabigatran etexilate that resulted in this fatal complication.
    Original languageEnglish
    Pages (from-to)115E-117E
    Number of pages3
    JournalAnnals of the Royal College of Surgeons of England
    Volume96
    Issue number1
    DOIs
    Publication statusPublished - Jan 2014

    Keywords

    • Aged
    • Antithrombins
    • Arthroplasty, Replacement, Hip
    • Benzimidazoles
    • Fatal Outcome
    • Female
    • Gastrointestinal Hemorrhage
    • Humans
    • Pyridines
    • Venous Thromboembolism

    Fingerprint

    Dive into the research topics of 'Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage'. Together they form a unique fingerprint.

    Cite this